Atrial fibrillation and microRNAs

Frontiers in Physiology

Volumn 5 JAN, Issue , 2014, Pages

  Santulli, Gaetano ^a,b   Iaccarino, Guido ^c,d   De Luca, Nicola ^a   Trimarco, Bruno ^a   Condorelli, Gianluigi ^e,f  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^b New York Presbyterian Hospital Manhattan ^*  (United States)

^c UNIVERSITY OF SALERNO   (Italy)

^d IRCCS MULTIMEDICA   (Italy)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Apoptosis; Atrial fibrillation; Electrical remodeling; Electrophysiology; Fibrosis; MicroRNA (miRNA); Structural remodeling

Indexed keywords

EID: 84893489424     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00015     Document Type: Short Survey

References (128)

1. Adam, O., Lohfelm, B., Thum, T., Gupta, S. K., Puhl, S. L., Schafers, H. J., et al. (2012). Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Res. Cardiol. 107, 278. doi: 10.1007/s00395-012-0278-0.
2. Akerman, A. W., and Mukherjee, R. (2013). MicroRNAs emerging as mediators of remodeling with atrial fibrillation. Heart Rhythm 10, 1010-1011. doi: 10.1016/j.hrthm.2013.03.021.
3. Ali, R., Huang, Y., Maher, S. E., Kim, R. W., Giordano, F. J., Tellides, G., et al. (2012). miR-1 mediated suppression of Sorcin regulates myocardial contractility through modulation of Ca2+ signaling. J. Mol. Cell. Cardiol. 52, 1027-1037. doi: 10.1016/j.yjmcc.2012.01.020.
4. Allessie, M., Ausma, J., and Schotten, U. (2002). Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc. Res. 54, 230-246. doi: 10.1016/S0008-6363(02)00258-4.
5. Ambros, V. (2004). The functions of animal microRNAs. Nature 431, 350-355. doi: 10.1038/nature02871.
6. Ambros, V., Bartel, B., Bartel, D. P., Burge, C. B., Carrington, J. C., Chen, X., et al. (2003). A uniform system for microRNA annotation. RNA 9, 277-279. doi: 10.1261/rna.2183803.
7. Anderson, M. E., and Mohler, P. J. (2007). MicroRNA may have macro effect on sudden death. Nat. Med. 13, 410-411. doi: 10.1038/nm0407-410.
8. Ando, Y., Yang, G. X., Kenny, T. P., Kawata, K., Zhang, W., Huang, W., et al. (2013). Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-beta receptor type II mouse. J. Autoimmun. 41, 111-119. doi: 10.1016/j.jaut.2012.12.013.
9. Anyukhovsky, E. P., Sosunov, E. A., Chandra, P., Rosen, T. S., Boyden, P. A., Danilo, P., et al. (2005). Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation. Cardiovasc. Res. 66, 353-363. doi: 10.1016/j.cardiores.2004.10.033.
10. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297. doi: 10.1016/S0092-8674(04)00045-5.
11. Beyerbach, D. M., and Zipes, D. P. (2004). Mortality as an endpoint in atrial fibrillation. Heart Rhythm 1, B8-B18. discussion: B18-B19. doi: 10.1016/j.hrthm.2004.04.018.
12. Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., et al. (2013). MicroRNA-34a regulates cardiac ageing and function. Nature 495, 107-110. doi: 10.1038/nature11919.
13. Brieger, D. B., and Freedman, S. B. (2009). Delirium cordis: can we predict the onset of atrial fibrillation? Lancet 373, 698-700. doi: 10.1016/S0140-6736(09)60415-3.
14. Brundel, B. J., Van Gelder, I. C., Henning, R. H., Tuinenburg, A. E., Wietses, M., Grandjean, J. G., et al. (2001). Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels. J. Am. Coll. Cardiol. 37, 926-932. doi: 10.1016/S0735-1097(00)01195-5.
15. Callis, T. E., Pandya, K., Seok, H. Y., Tang, R. H., Tatsuguchi, M., Huang, Z. P., et al. (2009). MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest. 119, 2772-2786. doi: 10.1172/JCI36154.
16. Care, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., et al. (2007). MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13, 613-618. doi: 10.1038/nm1582.
17. Conen, D., Chae, C. U., Glynn, R. J., Tedrow, U. B., Everett, B. M., Buring, J. E., et al. (2011). Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA 305, 2080-2087. doi: 10.1001/jama.2011.659.
18. Cooley, N., Cowley, M. J., Lin, R. C., Marasco, S., Wong, C., Kaye, D. M., et al. (2012). Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease. Physiol. Genomics 44, 211-219. doi: 10.1152/physiolgenomics.00111.2011.
19. Cullen, B. R. (2004). Transcription and processing of human microRNA precursors. Mol. Cell 16, 861-865. doi: 10.1016/j.molcel.2004.12.002.
20. D'Ascia, S. L., D'Ascia, C., Marino, V., Lombardi, A., Santulli, R., Chiariello, M., et al. (2011). Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in non-ischaemic dilated cardiomyopathy. Int. J. Clin. Pract. 65, 1149-1155. doi: 10.1111/j.1742-1241.2011.02732.x.
21. D'Ascia, S. L., Santulli, G., Liguori, V., Marino, V., Arturo, C., Chiariello, M., et al. (2010). Advanced algorithms can lead to electrocardiographic misinterpretations. Int. J. Cardiol. 141, e34-e36. doi: 10.1016/j.ijcard.2008.11.144.
22. Dawson, K., Wakili, R., Ordog, B., Clauss, S., Chen, Y., Iwasaki, Y., et al. (2013). MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation 127, 1466-1475, 1475e1-e28. doi: 10.1161/CIRCULATIONAHA.112.001207.
23. Delmar, M., and Makita, N. (2012). Cardiac connexins, mutations and arrhythmias. Curr. Opin. Cardiol. 27, 236-241. doi: 10.1097/HCO.0b013e328352220e.
24. Den Hoed, M., Eijgelsheim, M., Esko, T., Brundel, B. J., Peal, D. S., Evans, D. M., et al. (2013). Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat. Genet. 45, 621-631. doi: 10.1038/ng.2610.
25. Denli, A. M., Tops, B. B., Plasterk, R. H., Ketting, R. F., and Hannon, G. J. (2004). Processing of primary microRNAs by the Microprocessor complex. Nature 432, 231-235. doi: 10.1038/nature03049.
26. Dernellis, J., and Panaretou, M. (2006). Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation. Am. J. Cardiol. 97, 245-248. doi: 10.1016/j.amjcard.2005.08.027.
27. Dhamoon, A. S., and Jalife, J. (2005). The inward rectifier current (IK1) controls cardiac excitability and is involved in arrhythmogenesis. Heart Rhythm 2, 316-324. doi: 10.1016/j.hrthm.2004.11.012.
28. Duisters, R. F., Tijsen, A. J., Schroen, B., Leenders, J. J., Lentink, V., Van Der Made, I., et al. (2009). miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ. Res. 104, 170-178, 176p following 178. doi: 10.1161/CIRCRESAHA.108.182535.
29. Dvinge, H., Git, A., Graf, S., Salmon-Divon, M., Curtis, C., Sottoriva, A., et al. (2013). The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 497, 378-382. doi: 10.1038/nature12108.
30. Dweep, H., Sticht, C., Pandey, P., and Gretz, N. (2011). miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J. Biomed. Inform. 44, 839-847. doi: 10.1016/j.jbi.2011.05.002.
31. Fabian, M. R., and Sonenberg, N. (2012). The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat. Struct. Mol. Biol. 19, 586-593. doi: 10.1038/nsmb.2296.
32. Filipowicz, W., Bhattacharyya, S. N., and Sonenberg, N. (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9, 102-114. doi: 10.1038/nrg2290.
33. Frezzetti, D., De Menna, M., Zoppoli, P., Guerra, C., Ferraro, A., Bello, A. M., et al. (2011). Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene 30, 275-286. doi: 10.1038/onc.2010.416.
34. Friedman, R. C., Farh, K. K., Burge, C. B., and Bartel, D. P. (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105. doi: 10.1101/gr.082701.108.
35. Fye, W. B. (2006). Tracing atrial fibrillation-100 years. N. Engl. J. Med. 355, 1412-1414. doi: 10.1056/NEJMp068059.
36. Gan, Z., Rumsey, J., Hazen, B. C., Lai, L., Leone, T. C., Vega, R. B., et al. (2013). Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism. J. Clin. Invest. 123, 2564-2575. doi: 10.1172/JCI67652.
37. Garg, A., and Akoum, N. (2013). Atrial fibrillation and heart failure: beyond the heart rate. Curr. Opin. Cardiol. 28, 332-336. doi: 10.1097/HCO.0b013e32835fb710.
38. Girmatsion, Z., Biliczki, P., Bonauer, A., Wimmer-Greinecker, G., Scherer, M., Moritz, A., et al. (2009). Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. Heart Rhythm 6, 1802-1809. doi: 10.1016/j.hrthm.2009.08.035.
39. Goette, A. (2009). Nicotine, atrial fibrosis, and atrial fibrillation: do microRNAs help to clear the smoke? Cardiovasc. Res. 83, 421-422. doi: 10.1093/cvr/cvp188.
40. Goudis, C. A., Kallergis, E. M., and Vardas, P. E. (2012). Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation. Europace 14, 623-630. doi: 10.1093/europace/eur398.
41. Grueter, C. E., Van Rooij, E., Johnson, B. A., Deleon, S. M., Sutherland, L. B., Qi, X., et al. (2012). A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 149, 671-683. doi: 10.1016/j.cell.2012.03.029.
42. Guo, H., Ingolia, N. T., Weissman, J. S., and Bartel, D. P. (2010). Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840. doi: 10.1038/nature09267.
43. Haissaguerre, M., Hocini, M., Shah, A. J., Derval, N., Sacher, F., Jais, P., et al. (2013). Noninvasive panoramic mapping of human atrial fibrillation mechanisms: a feasibility report. J. Cardiovasc. Electrophysiol. 24, 711-717. doi: 10.1111/jce.12075.
44. Hale, C. S., and Levis, W. R. (2013). MicroRNA-29 and an integrated understanding of atrial fibrillation. J. Drugs Dermatol. 12, 1083.
45. Heymans, S., Corsten, M. F., Verhesen, W., Carai, P., Van Leeuwen, R. E., Custers, K., et al. (2013). Macrophage MicroRNA-155 promotes cardiac hypertrophy and failure. Circulation 128, 1420-1432. doi: 10.1161/CIRCULATIONAHA.112.001357.
46. Horie, T., Baba, O., Kuwabara, Y., Chujo, Y., Watanabe, S., Kinoshita, M., et al. (2012). MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/-mice. J. Am. Heart Assoc. 1:e003376. doi: 10.1161/JAHA.112.003376.
47. Hsu, S. D., Lin, F. M., Wu, W. Y., Liang, C., Huang, W. C., Chan, W. L., et al. (2011). miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 39, D163-D169. doi: 10.1093/nar/gkq1107.
48. Huikuri, H. V. (2008). Heart rate dynamics as a marker of vulnerability to atrial fibrillation. J. Cardiovasc. Electrophysiol. 19, 913-914. doi: 10.1111/j.1540-8167.2008.01197.x.
49. Jalife, J. (2011). Deja vu in the theories of atrial fibrillation dynamics. Cardiovasc. Res. 89, 766-775. doi: 10.1093/cvr/cvq364.
50. Jayaswal, V., Lutherborrow, M., Ma, D. D., and Yang, Y. H. (2011). Identification of microRNA-mRNA modules using microarray data. BMC Genomics 12:138. doi: 10.1186/1471-2164-12-138.
51. Kallen, A. N., Ma, J., and Huang, Y. (2012). Does Lin28 antagonize miRNA-mediated repression by displacing miRISC from target mRNAs? Front. Genet. 3:240. doi: 10.3389/fgene.2012.00240.
52. Kapur, S., and Macrae, C. A. (2013). The developmental basis of adult arrhythmia: atrial fibrillation as a paradigm. Front. Physiol. 4:221. doi: 10.3389/fphys.2013.00221.
53. Karakikes, I., Chaanine, A. H., Kang, S., Mukete, B. N., Jeong, D., Zhang, S., et al. (2013). Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J. Am. Heart Assoc. 2:e000078. doi: 10.1161/JAHA.113.000078.
54. Kim, G. H. (2013). MicroRNA regulation of cardiac conduction and arrhythmias. Transl. Res. 161, 381-392. doi: 10.1016/j.trsl.2012.12.004.
55. Kochegarov, A., Moses, A., Lian, W., Meyer, J., Hanna, M. C., and Lemanski, L. F. (2013). A new unique form of microRNA from human heart, microRNA-499c, promotes myofibril formation and rescues cardiac development in mutant axolotl embryos. J. Biomed. Sci. 20:20. doi: 10.1186/1423-0127-20-20.
56. Kushnir, A., and Marks, A. R. (2010). The ryanodine receptor in cardiac physiology and disease. Adv. Pharmacol. 59, 1-30. doi: 10.1016/S1054-3589(10)59001-X.
57. Lagos-Quintana, M., Rauhut, R., Lendeckel, W., and Tuschl, T. (2001). Identification of novel genes coding for small expressed RNAs. Science 294, 853-858. doi: 10.1126/science.1064921.
58. Latronico, M. V., and Condorelli, G. (2008). On the road to the definition of the cardiac miRNome in human disease states. J. Mol. Cell. Cardiol. 45, 162-164. doi: 10.1016/j.yjmcc.2008.05.018.
59. Latronico, M. V., and Condorelli, G. (2009). RNA silencing: small RNA-mediated posttranscriptional regulation of mRNA and the implications for heart electropathophysiology. J. Cardiovasc. Electrophysiol. 20, 230-237. doi: 10.1111/j.1540-8167.2008.01357.x.
60. Latronico, M. V., and Condorelli, G. (2013). MicroRNA-dependent control of the cardiac fibroblast secretome. Circ. Res. 113, 1099-1101. doi: 10.1161/CIRCRESAHA.113.302566.
61. Lee, G., Kumar, S., Teh, A., Madry, A., Spence, S., Larobina, M., et al. (2013). Epicardial wave mapping in human long-lasting persistent atrial fibrillation: transient rotational circuits, complex wavefronts, and disorganized activity. Eur. Heart J. 35, 86-97. doi: 10.1093/eurheartj/eht267.
62. Leucci, E., Patella, F., Waage, J., Holmstrom, K., Lindow, M., Porse, B., et al. (2013). microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci. Rep. 3:2535. doi: 10.1038/srep02535.
63. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20. doi: 10.1016/j.cell.2004.12.035.
64. Liang, Y., Ridzon, D., Wong, L., and Chen, C. (2007). Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8:166. doi: 10.1186/1471-2164-8-166.
65. Lindgren, K. S., Pekka Raatikainen, M. J., Juhani Airaksinen, K. E., and Huikuri, H. V. (2003). Relationship between the frequency of paroxysmal episodes of atrial fibrillation and pulmonary venous flow pattern. Europace 5, 17-23. doi: 10.1053/eupc.2002.0285.
66. Ling, T. Y., Wang, X. L., Chai, Q., Lau, T. W., Koestler, C. M., Park, S. J., et al. (2013). Regulation of the SK3 channel by microRNA-499-potential role in atrial fibrillation. Heart Rhythm 10, 1001-1009. doi: 10.1016/j.hrthm.2013.03.005.
67. Liu, X., Jin, D. Y., McManus, M. T., and Mourelatos, Z. (2012). Precursor microRNA-programmed silencing complex assembly pathways in mammals. Mol. Cell 46, 507-517. doi: 10.1016/j.molcel.2012.03.010.
68. Lu, Y., Zhang, Y., Wang, N., Pan, Z., Gao, X., Zhang, F., et al. (2010). MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 122, 2378-2387. doi: 10.1161/CIRCULATIONAHA.110.958967.
69. Lund, E., Guttinger, S., Calado, A., Dahlberg, J. E., and Kutay, U. (2004). Nuclear export of microRNA precursors. Science 303, 95-98. doi: 10.1126/science.1090599.
70. Luo, X., Pan, Z., Shan, H., Xiao, J., Sun, X., Wang, N., et al. (2013). MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J. Clin. Invest. 123, 1939-1951. doi: 10.1172/JCI62185.
71. Mahida, S. (2013). Transcription factors and atrial fibrillation. Cardiovasc. Res. doi: 10.1093/cvr/cvt261. [Epub ahead of print].
72. Marasovic, M., Zocco, M., and Halic, M. (2013). Argonaute and triman generate dicer-independent priRNAs and mature siRNAs to initiate heterochromatin formation. Mol. Cell. 52, 173-183. doi: 10.1016/j.molcel.2013.08.046.
73. Meijer, H. A., Kong, Y. W., Lu, W. T., Wilczynska, A., Spriggs, R. V., Robinson, S. W., et al. (2013). Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation. Science 340, 82-85. doi: 10.1126/science.1231197.
74. Menezes, A. R., Lavie, C. J., Dinicolantonio, J. J., O'Keefe, J., Morin, D. P., Khatib, S., et al. (2013). Atrial fibrillation in the 21st century: a current understanding of risk factors and primary prevention strategies. Mayo Clin. Proc. 88, 394-409. doi: 10.1016/j.mayocp.2013.01.022.
75. Musa, H., Carlton, L., Klos, M., Vikstrom, K., Anumonwo, J., Jalife, J., et al. (2013). Arrhythmogenesis in a novel murine model with KCNJ2 mutation of familial atrial fibrillation. Heart Rhythm 10, 1749. doi: 10.1016/j.hrthm.2013.09.077.
76. Nguyen, T. P., Qu, Z., and Weiss, J. N. (2013). Cardiac fibrosis and arrhythmogenesis: the road to repair is paved with perils. J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2013.10.018. [Epub ahead of print].
77. Nivala, M., Ko, C. Y., Nivala, M., Weiss, J. N., and Qu, Z. (2012). Criticality in intracellular calcium signaling in cardiac myocytes. Biophys. J. 102, 2433-2442. doi: 10.1016/j.bpj.2012.05.001.
78. Papait, R., Kunderfranco, P., Stirparo, G. G., Latronico, M. V., and Condorelli, G. (2013). Long noncoding RNA: a new player of heart failure? J. Cardiovasc. Transl. Res. 6, 876-883. doi: 10.1007/s12265-013-9488-6.
79. Perino, A., Ghigo, A., Ferrero, E., Morello, F., Santulli, G., Baillie, G. S., et al. (2011). Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110gamma. Mol. Cell 42, 84-95. doi: 10.1016/j.molcel.2011.01.030.
80. Pfaff, J., Hennig, J., Herzog, F., Aebersold, R., Sattler, M., Niessing, D., et al. (2013). Structural features of Argonaute-GW182 protein interactions. Proc. Natl. Acad. Sci. U.S.A. 110, E3770-E3779. doi: 10.1073/pnas.1308510110.
81. Qiao, A., Khechaduri, A., Kannan Mutharasan, R., Wu, R., Nagpal, V., and Ardehali, H. (2013). MicroRNA-210 decreases heme levels by targeting ferrochelatase in cardiomyocytes. J. Am. Heart Assoc. 2:e000121. doi: 10.1161/JAHA.113.000121.
82. Quiat, D., and Olson, E. N. (2013). MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J. Clin. Invest. 123, 11-18. doi: 10.1172/JCI62876.
83. Riley, A. B., and Manning, W. J. (2011). Atrial fibrillation: an epidemic in the elderly. Expert Rev. Cardiovasc. Ther. 9, 1081-1090. doi: 10.1586/erc.11.107.
84. Roth, B. M., Ishimaru, D., and Hennig, M. (2013). The core microprocessor component DiGeorge syndrome critical region 8 (DGCR8) is a nonspecific RNA-binding protein. J. Biol. Chem. 288, 26785-26799. doi: 10.1074/jbc.M112.446880.
85. Ruby, J. G., Jan, C. H., and Bartel, D. P. (2007). Intronic microRNA precursors that bypass Drosha processing. Nature 448, 83-86. doi: 10.1038/nature05983.
86. Ruvkun, G., Ambros, V., Coulson, A., Waterston, R., Sulston, J., and Horvitz, H. R. (1989). Molecular genetics of the Caenorhabditis elegans heterochronic gene lin-14. Genetics 121, 501-516.
87. Ruvkun, G., and Giusto, J. (1989). The Caenorhabditis elegans heterochronic gene lin-14 encodes a nuclear protein that forms a temporal developmental switch. Nature 338, 313-319. doi: 10.1038/338313a0.
88. Ruwald, A. C., Bloch Thomsen, P. E., Gang, U., Jorgensen, R. M., Huikuri, H. V., and Jons, C. (2013). New-onset atrial fibrillation predicts malignant arrhythmias in post-myocardial infarction patients-A Cardiac Arrhythmias and RIsk Stratification after acute Myocardial infarction (CARISMA) substudy. Am. Heart J. 166, 855-863.e853. doi: 10.1016/j.ahj.2013.08.017.
89. Santulli, G. (2012a). Coronary heart disease risk factors and mortality. JAMA 307, 1137. doi: 10.1001/jama.2012.323.
90. Santulli, G. (2012b). Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology 78, 840. doi: 10.1212/WNL.0b013e31824de51b.
91. Santulli, G. (2013). Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts. J. Cardiovasc. Dis. 1, 1-2.
92. Santulli, G., Ciccarelli, M., Trimarco, B., and Iaccarino, G. (2013). Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the beta adrenergic system. Front. Physiol. 4:209. doi: 10.3389/fphys.2013.00209.
93. Santulli, G., and D'Ascia, C. (2012). Atrial remodelling in echocardiographic super-responders to cardiac resynchronization therapy. Heart 98, 517. doi: 10.1136/heartjnl-2012-301731.
94. Santulli, G., D'Ascia, S., and D'Ascia, C. (2012a). Regarding the impact of left ventricular size on response to cardiac resynchronization therapy. Am. Heart J. 163, e11. doi: 10.1016/j.ahj.2012.01.001.
95. Santulli, G., D'Ascia, S. L., and D'Ascia, C. (2012b). Development of atrial fibrillation in recipients of cardiac resynchronization therapy: the role of atrial reverse remodelling. Can. J. Cardiol. 28, 245.e217. doi: 10.1016/j.cjca.2011.11.001.
96. Santulli, G., D'Ascia, S., Marino, V., and D'Ascia, C. (2012c). Atrial function in patients undergoing CRT. JACC Cardiovasc. Imaging 5, 124-125. doi: 10.1016/j.jcmg.2011.11.002.
97. Santulli, G., and Iaccarino, G. (2013). Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes. Immun. Ageing 10:10. doi: 10.1186/1742-4933-10-10.
98. Santulli, G., and Totary-Jain, H. (2013). Tailoring mTOR-based therapy: molecular evidence and clinical challenges. Pharmacogenomics 14, 1517-1526. doi: 10.2217/pgs.13.143.
99. Saxena, A., and Tabin, C. J. (2010). miRNA-processing enzyme Dicer is necessary for cardiac outflow tract alignment and chamber septation. Proc. Natl. Acad. Sci. U.S.A. 107, 87-91. doi: 10.1073/pnas.0912870107.
100. Shah, A. J., Hocini, M., Xhaet, O., Pascale, P., Roten, L., Wilton, S. B., et al. (2013). Validation of novel 3-dimensional electrocardiographic mapping of atrial tachycardias by invasive mapping and ablation: a multicenter study. J. Am. Coll. Cardiol. 62, 889-897. doi: 10.1016/j.jacc.2013.03.082.
101. Shan, H., Li, X., Pan, Z., Zhang, L., Cai, B., Zhang, Y., et al. (2009). Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1. Br. J. Pharmacol. 158, 1227-1235. doi: 10.1111/j.1476-5381.2009.00377.x.
102. Shen, J., Xia, W., Khotskaya, Y. B., Huo, L., Nakanishi, K., Lim, S. O., et al. (2013). EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497, 383-387. doi: 10.1038/nature12080.
103. Shiohama, A., Sasaki, T., Noda, S., Minoshima, S., and Shimizu, N. (2003). Molecular cloning and expression analysis of a novel gene DGCR8 located in the DiGeorge syndrome chromosomal region. Biochem. Biophys. Res. Commun. 304, 184-190. doi: 10.1016/S0006-291X(03)00554-0.
104. Siomi, H., and Siomi, M. C. (2009). On the road to reading the RNA-interference code. Nature 457, 396-404. doi: 10.1038/nature07754.
105. Siwik, D. A., and Colucci, W. S. (2004). Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail. Rev. 9, 43-51. doi: 10.1023/B:HREV.0000011393.40674.13.
106. Slagsvold, K. H., Rognmo, O., Hoydal, M. A., Wisloff, U., and Wahba, A. (2013). Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circ. Res. doi: 10.1161/CIRCRESAHA.114.302751. [Epub ahead of print].
107. Song, S. J., Poliseno, L., Song, M. S., Ala, U., Webster, K., Ng, C., et al. (2013). MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 154, 311-324. doi: 10.1016/j.cell.2013.06.026.
108. Straten, P., and Andersen, M. H. (2010). The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens. Oncotarget 1, 239-245.
109. Ter Keurs, H. E., and Boyden, P. A. (2007). Calcium and arrhythmogenesis. Physiol. Rev. 87, 457-506. doi: 10.1152/physrev.00011.2006.
110. Thomas, I. C., and Sorrentino, M. J. (2014). Bleeding risk prediction models in atrial fibrillation. Curr. Cardiol. Rep. 16, 432. doi: 10.1007/s11886-013-0432-9.
111. Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., et al. (2008). MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984. doi: 10.1038/nature07511.
112. Tritsch, E., Mallat, Y., Lefebvre, F., Diguet, N., Escoubet, B., Blanc, J., et al. (2013). An SRF/miR-1 axis regulates NCX1 and Annexin A5 protein levels in the normal and failing heart. Cardiovasc. Res. 98, 372-380. doi: 10.1093/cvr/cvt042.
113. Van Rooij, E., and Olson, E. N. (2012). MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat. Rev. Drug Discov. 11, 860-872. doi: 10.1038/nrd3864.
114. Vikman, S., Lindgren, K., Makikallio, T. H., Yli-Mayry, S., Airaksinen, K. E., and Huikuri, H. V. (2005). Heart rate turbulence after atrial premature beats before spontaneous onset of atrial fibrillation. J. Am. Coll. Cardiol. 45, 278-284. doi: 10.1016/j.jacc.2004.10.033.
115. Von Brandenstein, M., Richter, C., and Fries, J. W. (2012). MicroRNAs: small but amazing, and their association with endothelin. Life Sci. 91, 475-489. doi: 10.1016/j.lfs.2012.06.025.
116. Wang, Z., Lu, Y., and Yang, B. (2011). MicroRNAs and atrial fibrillation: new fundamentals. Cardiovasc. Res. 89, 710-721. doi: 10.1093/cvr/cvq350.
117. Witkos, T. M., Koscianska, E., and Krzyzosiak, W. J. (2011). Practical aspects of microRNA target prediction. Curr. Mol. Med. 11, 93-109. doi: 10.2174/156652411794859250.
118. Wu, P. H., Isaji, M., and Carthew, R. W. (2013). Functionally diverse microRNA effector complexes are regulated by extracellular signaling. Mol. Cell 52, 113-123. doi: 10.1016/j.molcel.2013.08.023.
119. Xie, W., Santulli, G., Guo, X., Gao, M., Chen, B. X., and Marks, A. R. (2013). Imaging atrial arrhythmic intracellular calcium in intact heart. J. Mol. Cell. Cardiol. 64, 120-123. doi: 10.1016/j.yjmcc.2013.09.003.
120. Yang, B., Lin, H., Xiao, J., Lu, Y., Luo, X., Li, B., et al. (2007). The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 13, 486-491. doi: 10.1038/nm1569.
121. Yates, L. A., Norbury, C. J., and Gilbert, R. J. (2013). The long and short of microRNA. Cell 153, 516-519. doi: 10.1016/j.cell.2013.04.003.
122. Zacharewicz, E., Lamon, S., and Russell, A. P. (2013). MicroRNAs in skeletal muscle and their regulation with exercise, ageing, and disease. Front. Physiol. 4:266. doi: 10.3389/fphys.2013.00266.
123. Zemlin, C. W., and Pertsov, A. M. (2007). Bradycardic onset of spiral wave re-entry: structural substrates. Europace 9(Suppl. 6), vi59-vi63. doi: 10.1093/europace/eum205.
124. Zeng, Y., Yi, R., and Cullen, B. R. (2005). Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J. 24, 138-148. doi: 10.1038/sj.emboj.7600491.
125. Zhang, R., Niu, H., Ban, T., Xu, L., Li, Y., Wang, N., et al. (2013a). Elevated plasma microRNA-1 predicts heart failure after acute myocardial infarction. Int. J. Cardiol. 166, 259-260. doi: 10.1016/j.ijcard.2012.09.108.
126. Zhang, Y., Sun, L., Zhang, Y., Liang, H., Li, X., Cai, R., et al. (2013b). Overexpression of microRNA-1 causes atrioventricular block in rodents. Int. J. Biol. Sci. 9, 455-462. doi: 10.7150/ijbs.4630.
127. Zhang, Y., Huang, Z. J., Dai, D. Z., Feng, Y., Na, T., Tang, X. Y., et al. (2008). Downregulated FKBP12.6 expression and upregulated endothelin signaling contribute to elevated diastolic calcium and arrhythmogenesis in rat cardiomyopathy produced by l-thyroxin. Int. J. Cardiol. 130, 463-471. doi: 10.1016/j.ijcard.2008.05.018.
128. Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., Von Drehle, M., Muth, A. N., et al. (2007). Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129, 303-317. doi: 10.1016/j.cell.2007.03.030.